Hikma Takes Part in 56th World Economic Forum Annual Meeting in Davos, Switzerland

Hikma Pharmaceuticals PLC (Hikma, Group), the multinational pharmaceutical group and a long-standing Health Industry Partner of the World Economic Forum (WEF), joined global leaders from government, business, civil society and academia at the 56th Annual Meeting of the World Economic Forum. This latest edition was held in Davos, Switzerland, from 19 to 23 January 2026, under the theme ‘A Spirit of Dialogue’.

WEF 2026 convened nearly 3,000 leaders from more than 130 countries - including heads of state and government, chief executive officers, chairpersons and leading innovators - to address pressing global challenges and explore pathways for inclusive and sustainable growth. Discussions focused on five key themes: the importance of multistakeholder cooperation in a more contested world; unlocking new sources of growth; investing in people; responsibly deploying innovation at scale; and building prosperity within planetary boundaries.

Mazen Darwazah, Hikma’s Executive Vice Chairman and President of MENA, participated in a panel titled ‘Japan’s Turn’, which examined how Japan can leverage technological innovation, economic reform and demographic shifts to drive sustainable growth and reinforce its role as a global leader. During the discussion, Darwazah reflected on how Japanese industries and advanced technologies can contribute to sustainable development and healthcare resilience. Darwazah highlighted the Group’s strategic partnerships with Japanese pharmaceutical companies dating back to the 1980s, underscoring the role of cross-border collaboration in bolstering healthcare systems and supporting industrial development in emerging markets.

Commenting on the importance of collaboration, Darwazah stated, “The relationship between Japan and the MENA region, in particular, reflects a shared commitment to long-term partnership, grounded in mutual trust, cultural exchange and economic cooperation. By strengthening ties across business, academia and innovation, we can create new opportunities that enhance healthcare access and deliver meaningful impact supporting sustainable growth for our communities.”